ArticleBioinformatics (Oxford, England)2026
Convex approaches to isolate the shared and distinct genetic components of complex traits.
Article in Bioinformatics (Oxford, England), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
- Update of
Authors and funding
5 authors.
Funding
Abstract
motivationGroups of complex diseases, such as coronary heart disease, neuropsychiatric disorders, and cancers, often display overlapping clinical symptoms and pharmacological responses. Genetic variants with shared associations across diseases have the potential to help explain their underlying biological processes, but this sharing remains poorly understood.
resultsWe model the matrix of summary statistics of trait-associated genetic variants as the sum of a low-rank component-representing shared biological processes-and a sparse component representing disease-unique processes and arbitrarily corrupted or contaminated components. We introduce Clorinn, an open-source Python library that uses convex optimization algorithms to recover these components by minimizing a weighted combination of nuclear norm and L1 terms. Clorinn provides two significant benefits: (i) convex optimization guarantees reproducibility of the components and (ii) the low-rank "uncorrupted" matrix allows robust singular value decomposition and principal component analysis, which are otherwise highly sensitive to outliers and noise in the input matrix. In extensive simulations, we observe that Clorinn is uniquely able to recover the disease-group structure while remaining competitive on factor-level reconstruction error. We apply Clorinn to estimate 200 latent factors from GWAS summary statistics for 2110 phenotypes from the Pan-UK Biobank (N = 420 531 European-ancestry individuals) and 10 latent factors from 14 psychiatric disorders. AVAILABILITY AND IMPLEMENTATION: Clorinn is available at https://github.com/daklab/clorinn.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.